Join the Association of Community Cancer Centers (ACCC) and the American Society of Clinical Oncology (ASCO) for a special live webcast on how the COVID-19 pandemic presents a unique opportunity to better understand the effects of a disease outbreak on the delivery of high-quality cancer care and research.

Hear how the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) is collecting information about patterns of symptoms and severity of COVID-19 infection, the influences on the delivery of cancer care, and decision-making for future disease outbreaks.

Dr. Richard L. Schilsky, ASCO’s Chief Medical Officer and Executive Vice President, will discuss the critical need to capture and analyze this longitudinal data, review the data collection process, and outline future registry deliverables.

Dr. Randall A. Oyer, Medical Director, Oncology Program, Penn Medicine Lancaster General Health, and ACCC President, will discuss his experience as a participating practice in the ASCO Registry and how his program intends to use the data.

As part of the 2020-2021 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research, ACCC is exploring the impact of COVID-19 on all facets of cancer care, including the administration of—and patient access to—clinical trials. Learn how participating in the ASCO Registry will support this work.

Reserve your spot for the opportunity to have your questions answered by the architect of the registry and an engaged participating practice. A link to the archived webinar will be provided to all registrants.
Watch On-Demand Replay Download Slides

This webcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., and Pfizer, Inc.